Sinai Vein Stent Registry

计划入组 1,000 人 · 首次发布于 2015 年 11 月 9 日

Biologics And Clinical Immunology Cohort at Sinai

计划入组 800 人 · 首次发布于 2021 年 3 月 5 日

The Mount Sinai Diabetic Foot Ulcer Prospective Trial

计划入组 60 人 · 首次发布于 2018 年 1 月 19 日

galectin-3 inhibitors (Henry Ford Health System/G3 Pharmaceuticals)

MT-110（National Institutes of Health）

MT-5111

SINAI HEALTH SYSTEM

United States

Cedars-Sinai Health System

United States

Mount Sinai Health System, Inc.

United States

PharmAla Biotech to Supply LaNeo MDMA for Clinical Trials at Mt. Sinai, Harvard, and Johns Hopkins

Redesign Health and Cedars-Sinai Form Strategic Partnership to Launch Multiple Healthcare Companies

Sequana Medical Achieves First U.S. Commercial Implantation of alfapump® System at Mount Sinai Hospital